KCM
TLSI icon

Kennedy Capital Management’s TriSalus Life Sciences TLSI Stock Holding History

Kennedy Capital Management’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.94M Buy
+485,242
New +$2.38M 0.04% 423

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Kennedy Capital Management's TLSI Position: Q1 2026 in Review

Kennedy Capital Management opened a new position in TriSalus Life Sciences (TLSI) in Q1 2026: 485,242 shares worth $1.94M. The stake represents 0.04% of the portfolio and ranks #423 among its holdings.

84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • Kennedy Capital Management held 485,242 shares of TriSalus Life Sciences worth $1.94M as of Q1 2026.
  • TriSalus Life Sciences was a new Kennedy Capital Management position in Q1 2026.
  • TriSalus Life Sciences made up 0.04% of Kennedy Capital Management's portfolio in Q1 2026, its #423 holding.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.